Export control of viral genome sequences

Introduction

Export control of viral genome sequences refers to the legal regulation of transferring digital genetic information relating to viruses across national borders. Viral genome sequences contain information about the genetic composition of viruses and are used in vaccine development, disease surveillance, diagnostic research, epidemiological studies and biotechnology.

The international sharing of viral genetic information is important for public health because researchers use sequence data to identify emerging infections and develop medical countermeasures. However, certain viral genome information may raise biosecurity concerns because it could potentially be misused in activities prohibited by biological weapons laws.

Export control therefore attempts to balance scientific freedom, international research cooperation, public health protection and national security. The legal challenge is particularly complicated because digital genetic information can be transferred through online databases, research platforms, emails and international scientific collaborations without physically transporting biological samples.

Meaning and objectives of export control

Export control of viral genome sequences means imposing legal or administrative restrictions on the international transfer of specified digital genetic information, particularly where the information is considered sensitive or potentially relevant to biological security.

Such controls may involve reviewing the nature of the sequence information, the identity of the recipient, the intended research purpose and applicable national security restrictions.

The main objectives include:

Biosecurity protection: Preventing the misuse of sensitive biological information.

Public health protection: Supporting responsible sharing of information required for disease surveillance.

National security: Preventing unauthorised transfers of controlled scientific information.

Research accountability: Ensuring that institutions follow appropriate data-sharing policies.

International cooperation: Maintaining lawful scientific collaboration across countries.

Not every viral genome sequence is automatically controlled. Publicly available sequences used for ordinary scientific research generally require a different legal assessment from information specifically restricted under applicable export-control laws.

Legal framework in India

India does not currently have a single comprehensive statute specifically governing the export of all viral genome sequences. However, several existing laws and regulatory frameworks may apply.

1. Foreign Trade (Development and Regulation) Act, 1992

The Act provides the statutory framework for regulating imports and exports. Section 3 empowers the Central Government to regulate foreign trade.

India's SCOMET (Special Chemicals, Organisms, Materials, Equipment and Technologies) framework controls specified strategic and dual-use items. Relevant biological materials, equipment and technologies may fall within controlled categories depending on their technical characteristics and intended use.

However, a digital viral genome sequence should not automatically be treated as a controlled SCOMET item without examining the applicable control-list wording and legal classification.

2. Weapons of Mass Destruction and their Delivery Systems (Prohibition of Unlawful Activities) Act, 2005

The Act prohibits specified unlawful activities relating to weapons of mass destruction and their delivery systems. It also addresses transfers of relevant materials, equipment and technologies.

Where genetic information is connected with a prohibited biological weapons activity, the legal position may require examination under the Act and other applicable laws.

3. Information Technology Act, 2000

The Act provides the legal framework for electronic records, computer systems and certain forms of cyber-related misconduct. Sections 43 and 66 address specified unauthorised computer-related activities, while Section 72 concerns breach of confidentiality and privacy in circumstances covered by the provision.

These provisions may become relevant when viral genome databases are accessed or transferred unlawfully.

4. Digital Personal Data Protection Act, 2023

Where viral genome databases contain identifiable personal information, applicable data-protection obligations must be considered. Human genomic information may raise privacy concerns, particularly where it can be linked to an identifiable individual.

The Act's provisions must be applied subject to their commencement and applicable rules. It does not establish a general export-control prohibition covering all viral genome sequences.

5. Biological Diversity Act, 2002

The Act regulates access to biological resources and associated knowledge within its statutory scope. Its applicability depends on the nature of the biological material, information involved, parties and relevant statutory provisions. Digital sequence information should not automatically be assumed to fall within every provision governing physical biological resources.

International legal framework

1. Biological Weapons Convention, 1972

The Convention prohibits the development, production, acquisition and stockpiling of biological and toxin weapons. Article I establishes the central prohibition, while Article III addresses transfers to recipients for prohibited purposes.

Although the Convention does not create a comprehensive export-licensing system for viral genome databases, it establishes important international obligations against biological weapons proliferation.

2. Wassenaar Arrangement

The Wassenaar Arrangement coordinates export controls concerning conventional arms and dual-use goods and technologies. Its control lists may cover certain advanced technologies, software and related equipment.

However, it should not be interpreted as automatically controlling every publicly available viral genome sequence.

3. Australia Group

The Australia Group coordinates national export-control measures concerning chemical and biological weapons-related materials, equipment and technologies. Its control lists and guidelines help participating governments prevent transfers that could support prohibited weapons programmes.

4. Convention on Biological Diversity, 1992

The Convention provides an international framework for biodiversity conservation and sustainable use. Discussions concerning digital sequence information on genetic resources are relevant to questions of access, benefit-sharing and international scientific cooperation.

5. International Health Regulations, 2005

The IHR provide a framework for international cooperation in detecting and responding to public health emergencies. They support timely communication of public health information, although they do not create a universal export-control licensing system for viral genome sequences.

Important judicial decisions

There are no direct Indian Supreme Court judgments specifically dealing with export control of viral genome sequences. However, several decisions establish relevant principles concerning privacy, scientific information and public health.

1. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

The Supreme Court recognised privacy as a fundamental right under Article 21. This judgment is relevant where viral genome databases contain identifiable human genetic information. It supports the need for lawful and proportionate handling of sensitive personal data.

2. Shreya Singhal v. Union of India (2015)

The Supreme Court invalidated Section 66A of the Information Technology Act because of its vague and overbroad restrictions on online speech. The judgment is relevant to digital information regulation because restrictions on scientific information transfers should have a clear legal basis and should not be arbitrary.

3. Gramophone Company of India Ltd. v. Birendra Bahadur Pandey (1984)

The Supreme Court examined the relationship between international law and domestic law. The judgment is relevant when considering India's domestic obligations under international biosecurity and public health frameworks.

4. Mr. X v. Hospital Z (1998)

The Supreme Court considered confidentiality and disclosure of sensitive medical information in a public-health context. The judgment is relevant by analogy where genetic or medical information is shared and competing privacy and public-interest concerns arise.

5. Common Cause v. Union of India (2018)

The Supreme Court addressed dignity, autonomy and individual rights in the context of end-of-life medical decisions. Although unrelated directly to genome exports, its broader constitutional principles may inform legal discussions involving sensitive medical information and individual autonomy.

Major challenges and regulatory safeguards

Export control of viral genome sequences creates difficulties because digital information can be shared instantly across international platforms. It may also be difficult to distinguish ordinary scientific research from transfers presenting genuine biosecurity concerns.

Important safeguards include:

Establishing clear legal criteria for controlled genetic information.

Maintaining institutional data-access policies.

Verifying the legal status and intended purpose of international transfers.

Protecting identifiable human genomic information.

Maintaining records of authorised data-sharing activities.

Providing appropriate review procedures for restrictions on scientific collaboration.

Supporting international public-health information exchange.

Regulatory authorities should distinguish between publicly available scientific information, sensitive personal genomic data and information specifically restricted under applicable security laws.

Conclusion

Export control of viral genome sequences involves a complex relationship between biotechnology, digital information regulation, public health, privacy and national security. In India, the Foreign Trade Act, WMD Act, Information Technology Act and applicable data-protection laws provide parts of the relevant legal framework. International instruments such as the Biological Weapons Convention, Australia Group framework and International Health Regulations provide additional guidance. Although direct Indian judicial precedents on viral genome export controls are limited, constitutional decisions concerning privacy, digital information and confidentiality establish important principles. A balanced regulatory system should prevent prohibited misuse while preserving legitimate scientific research and international disease-surveillance cooperation.